Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,982Revenue (TTM) $M746Net Margin (%)-28.0Altman Z-Score10.1
Enterprise Value $M8,768EPS (TTM) $-1.4Operating Margin %-28.0Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-28.8Higher ROA y-yY
Price/Book7.410-y EBITDA Growth Rate %--Quick Ratio3.4Cash flow > EarningsY
Price/Sales12.05-y EBITDA Growth Rate %--Current Ratio3.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-11.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-16.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M153ROIC % (ttm)-20.3Gross Margin Increase y-yY

Gurus Latest Trades with ALKS

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ALKS is held by these investors:



ALKS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cooke ShanePresident, Alkermes plc 2017-03-21Sell1,900$60.09-2.01view
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. 2017-03-15Sell11,000$56.743.77view
FRATES JAMES MSVP, Alks Inc; CFO ALKS 2017-03-07Sell25,000$59.08-0.34view
Cooke ShanePresident, Alkermes plc 2017-03-02Sell20,000$60-1.87view
BREYER ROBERT ADirector 2017-03-02Sell4,000$60-1.87view
MITCHELL PAUL JDirector 2017-03-01Sell1,500$57.063.19view
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. 2017-02-16Sell11,000$56.683.88view
MITCHELL PAUL JDirector 2017-02-01Sell1,500$54.458.14view
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. 2017-01-17Sell11,983$54.328.39view
Cooke ShanePresident, Alkermes plc 2017-01-09Sell550$60.27-2.31view

Quarterly/Annual Reports about ALKS:

News about ALKS:

Articles On GuruFocus.com
Who Is Winning the Fight Against Opioid Abuse? Feb 27 2017 
Naltrexone Showing More Potential in Drug Addiction Treatment Market Feb 05 2017 
BioCorRx Receives New Funding for Opioid Drug Jan 22 2017 
US Prisons Experiment With Addiction Treatment for Inmates Nov 29 2016 
AvalonBay Communities, Equinix, Jarden, Alkermes Approach 52-Week Highs Jan 04 2016 
Best Health Care Investor Edward Owens Buys One New Health Care Stock in First Quarter Apr 30 2012 
Weekly CEO Sells Highlight: Herbalife, CNO Financial Group, Alkermes plc, and TransDigm Oct 08 2011 
Alkermes Inc. Reports Operating Results (10-Q) Feb 03 2011 
Weekly Guru Bargains Highlights: SKX, VRX, ALKS, DF, SVU Dec 05 2010 
Alkermes Inc. Reports Operating Results (10-Q) Nov 04 2010 

More From Other Websites
Alkermes to Present Data on Two-Month Dosing Option Of ARISTADA® at 16th International Congress on... Mar 20 2017
Alkermes to Present Data on Two-Month Dosing Option Of ARISTADA® at 16th International Congress on... Mar 20 2017
Companies Aiming for the Billion-Dollar Opioid Addiction Market Mar 18 2017
Alkermes Starts Phase III Study to Treat Multiple Sclerosis Mar 17 2017
Alkermes Initiates Phase 3 Gastrointestinal Tolerability Study of ALKS 8700 for Treatment of... Mar 16 2017
Alkermes Initiates Phase 3 Gastrointestinal Tolerability Study of ALKS 8700 for Treatment of... Mar 16 2017
Alkermes Plc breached its 50 day moving average in a Bearish Manner : ALKS-US : March 14, 2017 Mar 14 2017
ALKERMES PLC. Files SEC form 8-K, Other Events Mar 10 2017
[video]The 'Gnarly 9' Biotechs Will Test the FDA's Mettle Mar 08 2017
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle Mar 08 2017
Alkermes’ Corporate Presentation to be Webcast at the Barclays Global Healthcare Conference Mar 07 2017
Here’s What Mott Capital Management Thinks About Netflix, Alkermes, Vodafone & More Mar 02 2017
Alkermes’ Corporate Presentation to be Webcast at the Cowen and Company 37th Annual Health Care... Feb 28 2017
Alkermes’ Corporate Presentation to be Webcast at the Cowen and Company 37th Annual Health Care... Feb 28 2017
Drug Addiction Treatment Stocks to Watch Feb 22 2017
ALKERMES PLC. Financials Feb 22 2017
Alkermes Plc :ALKS-US: Earnings Analysis: 2016 By the Numbers : February 17, 2017 Feb 17 2017
ALKERMES PLC. Files SEC form 10-K, Annual Report Feb 17 2017
Stress boom to boost drug sales? Feb 16 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)